Cohn J R, Fye D L, Sills J M, Francos G C
Tubercle. 1985 Dec;66(4):289-93. doi: 10.1016/0041-3879(85)90066-2.
Renal failure is a rare complication associated with the use of rifampicin for the treatment of tuberculosis, usually occurring well into the course of therapy. The following is a report of 2 cases of rifampicin-induced renal insufficiency. In the first case oligo-anuric renal failure occurred on the thirteenth day of treatment, after the patient had taken only 9 doses of medication. The second case occurred in a patient who developed renal failure while on daily therapy in the hospital. A literature review revealed 83 other reported cases of rifampicin-induced renal insufficiency. Intermittent or interrupted therapy appears to be a significant risk factor for the development of this complication.
肾衰竭是使用利福平治疗结核病时罕见的并发症,通常在治疗过程中较晚出现。以下是2例利福平所致肾功能不全的报告。第一例在治疗第13天出现少尿-无尿型肾衰竭,此时患者仅服用了9剂药物。第二例发生在一名住院接受每日治疗时出现肾衰竭的患者身上。文献回顾显示还有83例其他报告的利福平所致肾功能不全病例。间歇性或中断治疗似乎是发生这种并发症的一个重要危险因素。